Global Point of Care Glucose Testing Market Report 2022-2026: Focus on Introducing Low-cost Test Strips Driving PoC Glucose Testing Markets - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Sep 29, 2022--

The "Global Point of Care Glucose Testing Market 2022-2026" report has been added to ResearchAndMarkets.com's offering.

The point of care glucose testing market is poised to grow by $ 972.07 mn during 2022-2026, accelerating at a CAGR of 5.44%

The market is driven by an increase in the number of diabetes cases and rising awareness about diabetes, a growing geriatric population, and increasing unmet medical needs for the diagnosis and management of diabetes. The point of care glucose testing market analysis includes type segment and geographic landscape.

The report on the point of care glucose testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment.

This study identifies the focus on introducing low-cost test strips as one of the prime reasons driving the point of care glucose testing market growth during the next few years. Also, the rising market adoption of electronic medical records (EMRS) and increasing demand for point-of-care testing will lead to sizable demand in the market.

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading points of care glucose testing market vendors. Also, the point of care glucose testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Key Topics Covered:

1 Executive Summary

1.1 Market overview

2 Market Landscape

2.1 Market ecosystem

3 Market Sizing

3.1 Market definition

3.2 Market segment analysis

3.3 Market size 2021

3.4 Market outlook: Forecast for 2021-2026

4 Five Forces Analysis

4.1 Five forces summary

4.2 Bargaining power of buyers

4.3 Bargaining power of suppliers

4.4 Threat of new entrants

4.5 Threat of substitutes

4.6 Threat of rivalry

4.7 Market condition

5 Market Segmentation by Type

5.1 Market segments

5.2 Comparison by Type

5.3 Strips - Market size and forecast 2021-2026

5.4 Lancets and lancing devices - Market size and forecast 2021-2026

5.5 Meters - Market size and forecast 2021-2026

5.6 Market opportunity by Type

6 Customer Landscape

6.1 Customer landscape overview

7 Geographic Landscape

7.1 Geographic segmentation

7.2 Geographic comparison

7.3 North America - Market size and forecast 2021-2026

7.4 Europe - Market size and forecast 2021-2026

7.5 Asia - Market size and forecast 2021-2026

7.6 Rest of World (ROW) - Market size and forecast 2021-2026

7.7 US - Market size and forecast 2021-2026

7.8 UK - Market size and forecast 2021-2026

7.9 China - Market size and forecast 2021-2026

7.10 Canada - Market size and forecast 2021-2026

7.11 India - Market size and forecast 2021-2026

7.12 Market opportunity By Geographical Landscape

8 Drivers, Challenges, and Trends

8.1 Market drivers

8.2 Market challenges

8.3 Impact of drivers and challenges

8.4 Market trends

9 Vendor Landscape

9.1 Overview

9.2 Vendor landscape

9.3 Landscape disruption

9.4 Industry risks

10 Vendor Analysis

10.1 Vendors covered

10.2 Market positioning of vendors

• Abbott Laboratories
• ACON Laboratories Inc.
• Bayer AG
• Becton Dickinson and Co.
• Danaher Corp.
• EKF Diagnostics Holdings Plc
• F. Hoffmann La Roche Ltd.
• Johnson and Johnson
• LifeScan IP Holdings LLC
• Nipro Corp.
• Nova Biomedical Corp.
• PHC Holdings Corp.
• Prodigy Diabetes Care LLC
• PTS Diagnostics
• Sekisui Medical Co. Ltd.
• Siemens Healthineers AG
• Trinity Biotech Plc
• Trivida Health Inc.

For more information about this report visit https://www.researchandmarkets.com/r/rq2nch

View source version on businesswire.com:https://www.businesswire.com/news/home/20220929005448/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: DIABETES HEALTH MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2022.